Login
Section Science

Relationships between addiction and the COMT rs4680 Gene Polymorphism

Hubungan antara kecanduan dan Polimorfisme Gen COMT rs4680
Vol. 10 No. 2 (2025): December:

Wael Sattar Jaber (1), Fulla Abd Alsattar Alriyahee (2)

(1) University of Basrah, College of education for pure sciences, Iraq
(2) University of Basrah, College of Education for Pure Sciences, Iraq
Fulltext View | Download

Abstract:

General Background: Addiction to drugs and alcohol is a complex neuropsychiatric disorder influenced by both environmental and genetic factors, particularly those affecting dopamine regulation. Specific Background: The catechol-O-methyltransferase (COMT) gene, particularly the rs4680 Val158Met polymorphism, plays a crucial role in dopamine metabolism and has been implicated in addiction susceptibility. Knowledge Gap: While several studies link COMT variants to substance use disorders, evidence from Middle Eastern populations, especially Iraq, remains limited. Aims: This study aimed to assess the association between the COMT rs4680 polymorphism and vulnerability to drug and alcohol addiction in an Iraqi male cohort. Results: Analysis of 90 samples revealed a significantly higher frequency of the A allele and AA genotype in addicts compared to controls. The AA genotype was associated with a 14.55-fold and 17.14-fold increased risk of drug and alcohol addiction, respectively, while the GA genotype showed intermediate risk. Novelty: This is among the first studies to examine this genetic association in an Iraqi context, highlighting the contribution of COMT polymorphism to addiction predisposition. Implications: The findings suggest potential for genetic screening and personalized intervention strategies targeting dopaminergic pathways in addiction prevention and treatment.
Highlight :




  • The A allele of the rs4680 polymorphism is significantly associated with increased addiction risk.




  • The AA genotype shows a strong correlation with both drug and alcohol addiction.




  • The GA genotype indicates moderate vulnerability to addictive behavior.




Keywords  : rs4680 Polymorphism, COMT Gene, Addiction, Drug Use, Alcohol Use


 

Downloads

Download data is not yet available.

References

F. Dahmardeh dan A. Rezaeifar, "Effect of rs4680 (Val158Met) Polymorphism of the COMT Gene on Opioid Addiction in an Iranian Population: A Case-Control Study," Gene Cell Tissue, vol. 6, no. 2, pp. e91912, Apr. 2019, doi: 10.5812/gct.91912.

American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing, 2022.

A. N. Ahmed, "The Role of Social Awareness in Protecting University Students from Drugs in the Current Stage: Iraq as a Model," Center for Educational and Psychological Research, University of Baghdad, pp. 1–29, 2018.

J. Chmielowiec et al., "Associations Between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients," Int. J. Environ. Res. Public Health, vol. 15, no. 10, 2018, doi: 10.3390/ijerph15102076.

D. Mier, P. Kirsch, dan A. Meyer-Lindenberg, "Neural Substrates of Pleiotropic Action of Genetic Variation in COMT: A Meta-Analysis," Mol. Psychiatry, 2009, doi: 10.1038/mp.2009.36.

A. E. Tammimäki dan P. T. Männistö, "Are Genetic Variants of COMT Associated with Addiction?" Pharmacogenet. Genomics, vol. 20, pp. 717–741, 2010, doi: 10.1097/FPC.0b013e328340bdf2.

E. M. Tunbridge et al., "The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction," CNS Neurol. Disord. Drug Targets, vol. 11, pp. 306–323, 2012, doi: 10.2174/187152712800672409.

J. Tenhunen et al., "Genomic Organization of the Human Catechol-O-Methyltransferase Gene and Its Expression From Two Distinct Promoters," Eur. J. Biochem., vol. 223, pp. 1049–1059, 1994.

E. M. Tunbridge, T. A. Lane, dan P. J. Harrison, "Expression of Multiple Catechol-O-Methyltransferase (COMT) mRNA Variants in Human Brain," Am. J. Med. Genet. B, vol. 144B, pp. 834–839, 2007.

K. Chmielowiec et al., "Associations Between the COMT rs4680 Gene Polymorphism and Personality Dimensions and Anxiety in Patients With a Diagnosis of Other Stimulants Dependence," Genes, vol. 13, no. 10, p. 1768, 2022, doi: 10.3390/genes13101768.

D. N. Salman, Relationship Between COMT and MAOA Genes Polymorphisms With Aggressive Behavior in Convicted People, MSc Thesis, University of Basrah, 2022.

N. J. Bray et al., "A Haplotype Implicated in Schizophrenia Susceptibility Is Associated With Reduced COMT Expression in Human Brain," Am. J. Hum. Genet., vol. 73, pp. 152–161, 2003, doi: 10.1086/376578.

E. L. Dempster et al., "The Quantification of COMT mRNA in Post Mortem Cerebellum Tissue: Diagnosis, Genotype, Methylation and Expression," BMC Med. Genet., vol. 7, p. 10, 2006, doi: 10.1186/1471-2350-7-10.

Y. Ji et al., "Breast Cancer Risk Reduction and Membrane-Bound Catechol-O-Methyltransferase Genetic Polymorphisms," Cancer Res., vol. 68, no. 14, pp. 5997–6005, 2008, doi: 10.1158/0008-5472.CAN-08-0043.

H. Xia, N. Wu, dan Y. Su, "Investigating the Genetic Basis of Theory of Mind (ToM): The Role of Catechol-O-Methyltransferase (COMT) Gene Polymorphisms," PLoS One, vol. 7, no. 11, p. e49768, 2012, doi: 10.1371/journal.pone.0049768.

J. A. Sonia et al., "Catechol-O-Methyltransferase and Dopamine Receptor D4 Gene Variants: Possible Association With Substance Abuse in Bangladeshi Male," PLoS One, vol. 16, no. 2, p. e0246462, 2021, doi: 10.1371/journal.pone.0246462.

D. N. Salman dan A. I. Al-Badran, "Relationship Between COMT and MAOA Genes Polymorphisms and Aggressive Behavior," J. Biotechnol. Biol., vol. 1, pp. 1–14, 2023, doi: 10.17303/jbb.2023.1.105.

X. Wang et al., "An Association Study Between Polymorphism of Alcohol Dehydrogenase (ADH1B), Aldehyde Dehydrogenase (ALDH2), Cytochrome (CYP4502E1), Catechol-O-Methyltransferase (COMT) and 5-Hydroxytryptamine Transporter (5-HTT) Genes in Yunnan Han Population With Alcohol Dependence," Afr. J. Biotechnol., vol. 10, no. 57, pp. 12164–12170, 2011, doi: 10.5897/AJB11.959.

R. Saloner et al., "COMT val158met Genotype Alters the Effects of Methamphetamine Dependence on Dopamine and Dopamine-Related Executive Function: Preliminary Findings," Psychiatry Res., vol. 292, p. 113269, 2020, doi: 10.1016/j.psychres.2020.113269.

W. R. Lovallo et al., "Early Life Adversity and Blunted Stress Reactivity as Predictors of Alcohol and Drug Use in Persons With COMT (rs4680) Val158Met Genotypes," Alcohol Clin. Exp. Res., vol. 43, no. 7, pp. 1519–1527, 2020, doi: 10.1111/acer.14079.

D. Czarnecki et al., "Initial Study on COMT and DRD2 Gene Polymorphisms as Well as the Influence of Temperament and Character Trait on the Severity of Alcohol Craving in Alcohol-Dependent Patients," J. Clin. Med., vol. 10, no. 5892, 2021, doi: 10.3390/jcm10245892.

J. P. Schacht et al., "Effects of Pharmacological and Genetic Regulation of COMT Activity in Alcohol Use Disorder: A Randomized, Placebo-Controlled Trial of Tolcapone," Neuropsychopharmacology, vol. 47, pp. 1953–1960, 2022, doi: 10.1038/s41386-022-01335-z.

J. Sambrook, E. Fritsch, dan T. Maniatis, Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.

A. S. Hatoum et al., "Multivariate Genome-Wide Association Meta-Analysis of Over 1 Million Subjects Identifies Loci Underlying Multiple Substance Use Disorders," Nat. Ment. Health, vol. 1, pp. 210–223, 2023, doi: 10.1038/s44220-023-00034-y.

R. L. Yu et al., "Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson’s Disease," Brain Sci., vol. 11, no. 3, p. 361, 2021, doi: 10.3390/brainsci11030361.

Y. Paloyelis et al., "DAT1 and COMT Effects on Delay Discounting and Trait Impulsivity in Male Adolescents With Attention Deficit/Hyperactivity Disorder and Healthy Controls," Neuropsychopharmacology, vol. 35, pp. 2414–2426, 2010, doi: 10.1038/npp.2010.124.

E. M. Tunbridge, P. J. Harrison, dan D. R. Weinberger, "Catechol-O-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond," Biol. Psychiatry, vol. 60, pp. 141–151, 2006, doi: 10.1016/j.biopsych.2005.10.024.

D. Barman et al., "A Meta-Analysis for Understanding the Role of the COMT Val158Met Variant in the Susceptibility to Alcoholism," Afr. J. Alcohol Drug Abuse, vol. 11, 2024, doi: 10.4314/ajada.v11i1.2.

C. Zhao et al., "Genetic Variations in Catechol-O-Methyltransferase Gene Are Associated With Levodopa Response Variability in Chinese Patients With Parkinson’s Disease," Sci. Rep., vol. 10, p. 9521, 2020, doi: 10.1038/s41598-020-65332-2.

N. D. Volkow et al., "Imaging Dopamine’s Role in Drug Abuse and Addiction," Neuropharmacology, vol. 56, no. Suppl. 1, pp. 3–8, 2010, doi: 10.1016/j.neuropharm.2008.05.022.

J. Voisey et al., "A Novel SNP in COMT Is Associated With Alcohol Dependence but Not Opiate or Nicotine Dependence: A Case Control Study," Behav. Brain Funct., vol. 7, p. 51, 2011, doi: 10.1186/1744-9081-7-51.

X. Zhang et al., "Prefrontal White Matter Impairment in Substance Users Depends Upon the Catechol-O-Methyl Transferase (COMT) Val158Met Polymorphism," Neuroimage, vol. 69, pp. 62–69, Apr. 2013, doi: 10.1016/j.neuroimage.2012.11.056.